Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2161 stock hub

HKG/2161 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2161is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2161

In the news

Latest news · HKG/2161

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.5

P25 11.7P50 18.9P75 41.4

Trailing P/E10.1

P25 10.7P50 17.9P75 38.5

ROE20.4

P25 -14.7P50 2P75 9.4

ROIC17.4

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2161 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

HKD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	412
Employees Change	133%
Employees Change Percent	47.67
Enterprise value	HKD 2.2B
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG1090B1077
Last refreshed	2026-05-10
Market cap	HKD 2B
Price	HKD 2.48
Price currency	HKD
Rev Per Employee	1,973,259.71x
Sector	Healthcare
Sic	2834
Symbol	hkg/2161
Website	https://www.jbmhealthcare.com.hk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.68%
EV Earnings	10.28x
EV/EBIT	8.36x
EV/EBITDA	6.96x
EV/FCF	14.01x
EV/Sales	2.73x
FCF yield	7.83%
Forward P/E	9.47x
P/B ratio	1.79x
P/E ratio	10.07x
P/S ratio	2.49x
PE Ratio10 Y	24.78x
PE Ratio3 Y	8.54x
PE Ratio5 Y	9.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.64%
EBITDA Margin	37.05%
FCF margin	19.52%
Gross margin	56.76%
Gross Profit	HKD 461.4M
Gross Profit Growth	11.53%
Gross Profit Growth Q	23.17%
Gross Profit Growth3 Y	10.92%
Gross Profit Growth5 Y	17.56%
Net Income	HKD 216.4M
Net Income Growth	32.04%
Net Income Growth Q	19.95%
Net Income Growth Quarters	8%
Net Income Growth Years	4%
Net Income Growth3 Y	18.37%
Net Income Growth5 Y	30.54%
Pretax Margin	33.24%
Profit Margin	26.62%
Profit Per Employee	HKD 525,221
Profitable Years	8
ROA	10.43
Roa5y	5.14
ROCE	16.74
ROE	20.38
Roe5y	8.87
ROIC	17.36
Roic5y	9.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.44%
Cagr3y	40.62%
Cagr5y	13.23%
EPS Growth	26.41
EPS Growth Q	21.39
EPS Growth Quarters	8
EPS Growth Years	4
EPS Growth3 Y	18.59
EPS Growth5 Y	30.91
FCF Growth	-37.63%
FCF Growth Q	-38.16%
FCF Growth3 Y	-4.3%
FCF Growth5 Y	2.91%
OCF Growth	-27.84%
OCF Growth Q	-29.4%
OCF Growth10 Y	12.73%
OCF Growth3 Y	-0.45%
OCF Growth5 Y	5.31%
Revenue Growth	12.83x
Revenue Growth Q	7.69x
Revenue Growth Quarters	8x
Revenue Growth Years	7x
Revenue Growth3 Y	7.83x
Revenue Growth5 Y	9.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.51
Assets	HKD 1.8B
Cash	HKD 238.6M
Current Assets	HKD 542M
Current Liabilities	HKD 186.4M
Debt	HKD 374.4M
Debt EBITDA	HKD 1.17
Debt Equity	HKD 0.33
Debt FCF	HKD 2.36
Equity	HKD 1.1B
Interest Coverage	47.67
Liabilities	HKD 640.1M
Long Term Assets	HKD 1.2B
Long Term Liabilities	HKD 453.7M
Net Cash	HKD -135.8M
Net Cash By Market Cap	HKD -6.7
Net Debt EBITDA	HKD 0.45
Net Debt Equity	HKD 0.12
Net Debt FCF	HKD 0.86
Tangible Book Value	HKD 57.4M
Tangible Book Value Per Share	HKD 0.07
WACC	5.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.91
Inventory Turnover	3.76
Net Working Capital	HKD 152.5M
Quick ratio	2.41
Working Capital	HKD 355.6M
Working Capital Turnover	HKD 3.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.46%
Dividend Growth	122.51%
Dividend Growth Years	4%
Dividend per share	HKD 0.2
Dividend Years	4
Dividend Yield	7.86%
Ex Div Date	2025-11-28
Last Dividend	HKD 0.1
Payout Frequency	Semi-Annual
Payout Ratio	64.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.42%
200-day SMA	2.82
3Y total return	178.12%
50-day SMA	2.65
50-day SMA vs 200-day SMA	50under200
5Y total return	86.12%
All Time High	3.43
All Time High Change	-27.7%
All Time High Date	2025-07-02
All Time Low	0.54
All Time Low Change	362.51%
All Time Low Date	2022-11-03
ATR	0.06
Beta	0.34
Beta1y	0.39
Beta2y	0.5
Ch YTD	-6.77
High	2.56
High52	3.43
High52 Date	2025-07-02
High52ch	-27.7%
Low	2.43
Low52	2.07
Low52 Date	2025-05-19
Low52ch	19.81%
Ma50ch	-6.34%
Price vs 200-day SMA	-12.15%
RSI	39.79
RSI Monthly	56.5
RSI Weekly	38.17
Sharpe ratio	0.6x
Sortino ratio	1.34
Total Return	3.41%
Tr YTD	-6.77
Tr1m	-6.42%
Tr1w	0.81%
Tr3m	-6.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 265.4M
Operating Income Growth	13.61
Operating Income Growth Q	27.88
Operating Income Growth3 Y	17.82
Operating Income Growth5 Y	30.36
Operating margin	32.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	209,722,644%
Net Borrowing	262,025,000
Shares Insiders	34.84%
Shares Institutions	0.16%
Shares Out	817,300,000
Shares Qo Q	-13.62%
Shares Yo Y	4.46%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 153M
Average Volume	411,742.35x
Bv Per Share	1.31
CAPEX	HKD -30M
Ch1m	-6.42
Ch1w	0.81
Ch1y	11.21
Ch3m	-6.06
Ch3y	127.5
Ch5y	51.22
Ch6m	-13.29
Change	0.81%
Change From Open	0.81
Close	2.46
Days Gap	0
Depreciation Amortization	35,858,000
Dollar Volume	1,205,280
Earnings Date	2026-06-12
EBIT	HKD 265.4M
EBITDA	HKD 301.2M
EPS	HKD 0.25
F Score	5
FCF	HKD 158.7M
FCF EV Yield	7.14x
FCF Per Share	HKD 0.19
Financing CF	77,441,000
Fiscal Year End	March
Founded	2,020
Graham Number	2.6945
Graham Upside	8.65
Income Tax	HKD 46.1M
Investing CF	-227,558,000
Is Primary Listing	1
Last Earnings Date	2026-02-16
Last Report Date	2025-09-30
Lynch Fair Value	HKD 6.16
Lynch Upside	148.2
Ma150	2.76
Ma150ch	-10.24%
Ma20	2.55
Ma20ch	-2.71%
Net CF	38,512,000
Next Earnings Date	2026-06-12
Open	2.46
P FCF Ratio	12.78
P OCF Ratio	10.74
Payment Date	2025-12-17
Position In Range	38.46
Ppne	169,257,000
Price Date	2026-05-08
Price EBITDA	HKD 6.73
Ptbv Ratio	35.34
Relative Volume	1.21x
Revenue	812,983,000x
SBC By Revenue	0.69x
Share Based Comp	5,616,000
Tax By Revenue	5.68x
Tax Rate	17.08%
Tr6m	-10.37%
Volume	486,000
Z Score	3.23

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/2161 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.9%

$0.20 annual per share

Payout ratio

+64.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

4 consecutive years of growth

Total shareholder yield

+3.4%

Next ex-dividend date: 2025-11-28

Performance

HKG/2161 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2161?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.2%

Share of float held by funds and institutions

Insider ownership

+34.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.5%

Negative means the company is buying back shares.

Technical

HKG/2161 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.8

Neutral momentum band

Price vs 200-day MA

-12.2%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2161

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2161 stock rating?

hkg/2161 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2161 analysis?

The full report lives at /stocks/hkg/2161/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2161?

The latest report frames hkg/2161 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2161 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.